Phio Pharmaceuticals (PHIO) Shares Outstanding (2011 - 2026)

Phio Pharmaceuticals (PHIO) has reported Shares Outstanding (Entity) for 16 consecutive years, with $11.6 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Shares Outstanding (Entity) rose 142.12% year-over-year to $11.6 million; the trailing twelve-month figure through Jun 2026 stood at $11.6 million (up 142.12% YoY), and the FY2025 full-year result was $6.0 million, up 659.91% from the prior year.
• Shares Outstanding (Entity) held at $11.6 million in Q2 2026 per PHIO's latest filing, from $11.6 million in the prior quarter.
• Across five years, Shares Outstanding (Entity) topped out at $11.6 million in Q1 2026 and bottomed at $126463.0 in Q1 2022.
• Historically, Shares Outstanding (Entity) has averaged $2.7 million across 5 years, with a median of $510186.0 in 2024.
• The sharpest annual moves came in 2022 and 2025: Shares Outstanding (Entity) advanced 0.92% in 2022, then surged 840.47% in 2025.
• Over 5 years, Shares Outstanding (Entity) stood at $126557.0 in 2022, then surged by 82.93% to $231505.0 in 2023, then jumped by 240.15% to $787466.0 in 2024, then soared by 659.91% to $6.0 million in 2025, then surged by 94.14% to $11.6 million in 2026.
• According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $11.6 million, $11.6 million, and $6.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.